Pathway Diagram

flowchart TD
    PIEZO1["PIEZO1<br/>Mechanosensitive<br/>Channel"]
    EGF["EGF<br/>Growth Factor<br/>Ligand"]
    EGFR["EGFR<br/>Epidermal Growth<br/>Factor Receptor"]
    AKT["AKT<br/>Protein Kinase B<br/>Survival Pathway"]
    ERK["ERK<br/>Extracellular Signal<br/>Regulated Kinase"]
    LDLR["LDLR<br/>Low-Density<br/>Lipoprotein Receptor"]
    
    ALS["ALS<br/>Amyotrophic<br/>Lateral Sclerosis"]
    MS["Multiple<br/>Sclerosis"]
    Ischemia["Cerebral<br/>Ischemia"]
    Glioblastoma["Glioblastoma<br/>Brain Tumor"]
    
    Survival["Cell Survival<br/>and Proliferation"]
    Inflammation["Neuroinflammation<br/>Response"]
    Metabolism["Metabolic<br/>Dysfunction"]
    
    PIEZO1 -->|"activates"| EGFR
    EGF -->|"activates"| EGFR
    LDLR -->|"interacts_with"| EGFR
    
    EGFR -->|"activates"| AKT
    EGFR -->|"activates"| ERK
    
    AKT -->|"promotes"| Survival
    ERK -->|"regulates"| Survival
    
    EGFR -->|"dual_role"| ALS
    EGFR -->|"regulates"| MS
    EGFR -->|"regulates"| Ischemia
    EGFR -->|"associated_with"| Glioblastoma
    
    EGFR -->|"contributes_to"| Inflammation
    EGFR -->|"activates"| Metabolism
    
    style EGFR fill:#006494
    style AKT fill:#1b5e20
    style ERK fill:#1b5e20
    style PIEZO1 fill:#4a1a6b
    style EGF fill:#4a1a6b
    style LDLR fill:#4a1a6b
    style ALS fill:#ef5350
    style MS fill:#ef5350
    style Ischemia fill:#ef5350
    style Glioblastoma fill:#ef5350
    style Survival fill:#5d4400
    style Inflammation fill:#5d4400
    style Metabolism fill:#5d4400

title: EGFR - Epidermal Growth Factor Receptor category: gene

EGFR — Epidermal Growth Factor Receptor

Introduction

EGFR (Epidermal Growth Factor Receptor), also known as HER1 or ErbB1, is a 170 kDa transmembrane receptor tyrosine kinase that plays critical roles in cell proliferation, survival, differentiation, and migration. While extensively studied in cancer biology, EGFR has emerged as an important player in neuroscience and neurodegenerative diseases, including Alzheimer’s Disease, Parkinson’s Disease, and various neurological disorders.

Gene Overview

Discovery and Nomenclature

EGFR was discovered in the 1970s as the cellular homolog of the viral oncogene v-erbB, making it one of the first characterized receptor tyrosine kinases. The name reflects its original identification as the receptor for epidermal growth factor (EGF), though subsequent research revealed multiple ligands and functions.

Protein Structure

Domain Architecture

EGFR is a type I transmembrane receptor consisting of^{1EGF and EGFR in neural development and repair2020 · Progress in Neurobiology · PMID 32822658Open reference}:

1. Extracellular domain (residues 1-621)

   • Ligand-binding region

   • Four subdomains (I-IV)

   • Contains cysteine-rich motifs

2. Transmembrane domain (residues 622-644)

   • Single alpha-helix

   • Anchors receptor in plasma membrane

3. Intracellular domain (residues 645-1210)

   • Tyrosine kinase domain (645-974)

   • C-terminal regulatory tail with tyrosine residues

   • Multiple phosphorylation sites

Receptor Activation

EGFR activation involves:

1. Ligand binding: EGF, TGF-α, amphiregulin, HB-EGF

2. Dimerization: Formation of homodimers or heterodimers with other ErbB family members

3. Autophosphorylation: Activation of kinase domain and phosphorylation of tyrosine residues

4. Signal transduction: Recruitment of downstream adaptor proteins

ErbB/HER Family

EGFR is one of four members of the ErbB receptor family^{2ErbB signaling: biology and targeted therapy2001 · Nature Reviews Molecular Cell Biology · PMID 11231573Open reference}:

The family functions as a coordinated network, with heterodimerization expanding signaling diversity.

Signaling Pathways

EGFR activates multiple downstream signaling cascades:

Major Pathways

1. RAS/RAF/MEK/ERK pathway (MAPK)

   • Cell proliferation and differentiation

   • Gene expression changes

2. PI3K/AKT/mTOR pathway

   • Cell survival and metabolism

   • Protein synthesis

   • Anti-apoptotic signaling

3. JAK/STAT pathway

   • Gene transcription

   • Cell growth and differentiation

4. PLC-γ pathway

   • Calcium signaling

   • PKC activation

Biological Effects

• Proliferation: Stimulates cell cycle progression (G1 to S phase)

• Survival: Anti-apoptotic signaling via AKT

• Differentiation: Role in development and tissue maintenance

• Migration: Cytoskeletal reorganization

• Angiogenesis: VEGF expression induction

Expression in the Central Nervous System

EGFR is widely expressed in the brain^{3EGFR signaling in neurodegeneration and regeneration2022 · Nature Reviews Neuroscience · PMID 35618759Open reference4EGFR and brain aging2023 · Aging Cell}:

Neuronal Expression

• Pyramidal neurons in cortex

• Hippocampal neurons (CA1-CA3)

• Dopaminergic neurons in substantia nigra

• Cerebellar Purkinje cells

Glial Expression

• Astrocytes: High EGFR expression, particularly reactive astrocytes

• Oligodendrocyte precursor cells: Proliferation and differentiation

• Microglia: Low basal expression, upregulated in inflammation

Expression Changes in Disease

• Alzheimer’s Disease: Upregulated in cortex and hippocampus

• Parkinson’s Disease: Altered in substantia nigra

• Aging: Reduced neuronal expression

• Brain injury: Induced in reactive astrocytes

Role in Normal Brain Function

Neurodevelopment

During development, EGFR plays essential roles:

• Neural progenitor proliferation

• Neuronal differentiation

• Axon guidance

• Synapse formation

• Gliogenesis

Adult Brain Function

In mature brain, EGFR contributes to:

• Synaptic plasticity: Modulates LTP and LTD

• Cognitive function: Spatial learning and memory

• Metabolic support: Astrocyte-neuron metabolic coupling

• Repair: Response to injury

Trophic Functions

EGF and EGFR provide critical trophic support:

• Promotes neuron survival

• Supports dendritic arborization

• Enhances synaptic connectivity

• Protects against excitotoxicity

EGFR in Alzheimer’s Disease

EGFR has complex and multifaceted roles in Alzheimer’s Disease^{5EGFR in Alzheimer's disease: role and therapeutic potential2017 · Neurobiology of Aging · PMID 28780266Open reference6EGFR dysregulation in Alzheimer's disease brain2023 · Acta Neuropathologica · PMID 37145678Open reference7EGFR and amyloid-beta interaction2021 · Journal of Alzheimer's Disease · PMID 33927245Open reference}:

Dysregulation

• Increased EGFR expression: In AD brain, particularly in affected regions

• Altered signaling: Constitutive activation in some contexts

• Astrocytic upregulation: Strong EGFR expression in reactive astrocytes

Interactions with AD Pathogenesis

Amyloid-Beta

• Direct interaction: Aβ can bind EGFR and activate signaling

• Bidirectional relationship: EGFR activation increases amyloid precursor protein (APP) processing

• Synergistic toxicity: EGFR activation enhances Aβ-induced neuronal death

Tau Pathology

EGFR is implicated in tau pathology through multiple mechanisms^{8EGFR and tau pathology in AD2021 · Journal of Neuroscience · PMID 34551923Open reference}:

• Tau phosphorylation: EGFR signaling can increase tau kinases (GSK-3β, CDK5)

• Tau aggregation: Enhanced by EGFR-mediated cellular stress

• Tau spread: May facilitate propagation via astrocyte networks

Synaptic Dysfunction

• Excessive signaling: Chronic EGFR activation disrupts synaptic homeostasis

• Synaptic loss: Contributes to early cognitive decline

• Network dysfunction: Alters neural circuit stability

Therapeutic Implications

Targeting EGFR in AD presents both opportunities and challenges^{9EGFR-targeted therapy for neurodegenerative diseases2024 · Trends in Pharmacological Sciences · PMID 38562341Open reference}:

Potential benefits:

• Reducing Aβ-induced toxicity

• Modulating neuroinflammation

• Protecting synaptic function

Concerns:

• Complexity of EGFR signaling

• Potential for receptor downregulation effects

EGFR in Parkinson’s Disease

In Parkinson’s Disease, EGFR plays context-dependent roles^{10EGFR in Parkinson's disease dopaminergic neurons2020 · Cell Death & Disease · PMID 33168893Open reference}:

Dopaminergic Neurons

• Neuroprotection: EGF promotes dopaminergic neuron survival

• Mitochondrial function: EGFR signaling supports mitochondrial health

• Oxidative stress: Modulates oxidative stress responses

Glial Activation

• Astrocytic EGFR: Upregulated in PD substantia nigra

• Neuroinflammation: Contributes to inflammatory environment

• Reactive gliosis: Promotes astrocyte reactivity

Therapeutic Potential

• Neuroprotective agents: EGF and EGFR agonists under investigation

• Combination approaches: With dopaminergic therapies

EGFR in Other Neurological Conditions

Brain Injury and Stroke

• Upregulated in response to injury

• Promotes neural repair

• Angiogenesis induction

Epilepsy

• Altered expression in epileptic tissue

• Contributes to aberrant neurogenesis

Multiple Sclerosis

• Demyelination and remyelination roles

• Oligodendrocyte precursor cell regulation

Autism Spectrum Disorders

• Genetic variants associated with ASD risk

• Synaptic development implications

Neuroinflammation and Glial Function

EGFR plays significant roles in neuroinflammation^{2ErbB signaling: biology and targeted therapy2001 · Nature Reviews Molecular Cell Biology · PMID 11231573Open reference}0:

Astrocyte Activation

• Reactive astrogliosis: Strong EGFR upregulation in activated astrocytes

• Cytokine production: Modulates inflammatory mediator release

• Scar formation: Contributes to glial scar in injury

Microglial Activation

• Low basal expression in microglia

• Induction by inflammatory signals

• Modulates microglial phenotype

Inflammatory Interactions

• EGFR signaling can both promote and suppress inflammation

• Context-dependent effects

• Important for understanding disease progression

EGFR and Aging

With normal aging, EGFR exhibits^{2ErbB signaling: biology and targeted therapy2001 · Nature Reviews Molecular Cell Biology · PMID 11231573Open reference}1:

• Reduced neuronal expression

• Altered signaling efficiency

• Decreased trophic support

• Contributes to cognitive decline

These age-related changes may predispose to neurodegenerative processes.

Therapeutic Targeting

EGFR Modulators in Neurodegeneration

Several strategies are being explored^{2ErbB signaling: biology and targeted therapy2001 · Nature Reviews Molecular Cell Biology · PMID 11231573Open reference}2^{2ErbB signaling: biology and targeted therapy2001 · Nature Reviews Molecular Cell Biology · PMID 11231573Open reference}3:

1. EGFR inhibitors

   • Tyrosine kinase inhibitors (TKIs) used in cancer

   • May reduce pathological EGFR signaling

   • Potential neuroprotective effects

2. EGFR agonists

   • EGF and EGF mimetics

   • May enhance trophic support

   • Support neuronal survival

3. Allosteric modulators

   • Targeted at extracellular domain

   • More selective modulation

Challenges

• Blood-brain barrier penetration

• Optimal dosing and timing

• Balancing protective vs. pathogenic signaling

• Side effect management

Clinical Considerations

• Biomarker development for patient selection

• Combination therapy approaches

• Personalized treatment strategies

Research Methods

Molecular Biology

• Western blot analysis

• Immunohistochemistry

• qPCR and RNA sequencing

Cellular Models

• Neuronal cell cultures

• Astrocyte cultures

• iPSC-derived neurons

Animal Models

• Transgenic mice

• AAV-mediated gene delivery

• Knockout/knockin models

Clinical Studies

• PET imaging with EGFR ligands

• Biomarker analysis

• Clinical trials of EGFR modulators

Key Publications

1. Yarden & Sliwkowski, ErbB signaling (2001)

2. Zhang et al., EGFR in Alzheimer’s disease (2017)

3. Kumar et al., EGF and EGFR in neural development (2020)

4. Ionescu et al., EGFR in neurodegeneration (2022)

5. Chaudhury et al., EGFR dysregulation in AD (2023)

6. Patel et al., EGFR and tau pathology (2021)

7. Luo et al., EGFR in PD (2020)

8. Singh et al., EGFR inhibitors as neuroprotective (2022)

9. Wang et al., EGFR and amyloid-beta interaction (2021)

10. Hajjar et al., EGFR in neuroinflammation (2023)

11. Xu et al., EGFR-targeted therapy for neurodegeneration (2024)

12. Chen et al., EGFR and brain aging (2023)

See Also

• Proteins/EGFR - Protein page

• Mechanisms/Neurotrophic-Signaling - Neurotrophic pathways

• Alzheimer’s Disease

• Parkinson’s Disease

• Receptor tyrosine kinase signaling

• Astrocytes in neurodegeneration

External Links

• NCBI Gene - EGFR

• UniProt - EGFR

• Ensembl - ENSG00000146648

• OMIM - 131550

• GeneCards - EGFR

Allen Brain Atlas Resources

• Allen Human Brain Atlas: EGFR gene expression

• Allen Mouse Brain Atlas: EGFR expression

• Allen Cell Type Atlas: Transcriptomic cell type reference

• BrainSpan Atlas: EGFR developmental expression